Ravindra Prasan Rannan-Eliya

Ravindra Prasan Rannan-Eliya

Auto-generated profile, based on publicly available information

Ravindra Prasan Rannan-Eliya

Institute for Health Policy, Colombo, Sri Lanka

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in The Lancet
Verified
Journal Article
Closed access
EDEddy van Doorslaer
Eddy van Doorslaer
OOOwen O'Donnell
Owen O'Donnell
RRRavi P Rannan-Eliya
Ravi P Rannan-Eliya
ASAparnaa Somanathan
Aparnaa Somanathan
SAShiva Raj Adhikari
Shiva Raj Adhikari
YZYuxin Zhao
Yuxin Zhao

1 May 2015 in The Lancet
Verified
Journal Article
Open access
DHDavid L Heymann
David L Heymann
LCLincoln Chen
Lincoln Chen
KTKeizo Takemi
Keizo Takemi
DFDavid P Fidler
David P Fidler
JTJordan W Tappero
Jordan W Tappero
RRRavi P Rannan-Eliya
Ravi P Rannan-Eliya
The Ebola virus disease outbreak in West Africa was unprecedented in both its scale and impact. Out of this human calamity has come renewed attention to global health security--its definition, meaning, and the practical implications for programmes and policy. For example, how does a government begin to strengthen its core public health capacities, as demanded by the International Health Regulations? What counts as a global health security concern? In the context of the governance of global health, including WHO reform, it will be important to distil lessons learned from the Ebola outbreak. The Lancet invited a group of respected global health practitioners to reflect on these lessons, to explore the idea of global health security, and to offer suggestions for next steps. Their contributions describe some of the major threats to individual and collective human health, as well as the values and recommendations that should be considered to counteract such threats in the future. Many different perspectives are proposed. Their common goal is a more sustainable and resilient society for human health and wellbeing.

21 February 2007 in Health Economics
Verified
Journal Article
Closed access
PDF file
EDEddy Van Doorslaer
Eddy Van Doorslaer
OOOwen O'Donnell
Owen O'Donnell
RRRavindra P Rannan-Eliya
Ravindra P Rannan-Eliya
ASAparnaa Somanathan
Aparnaa Somanathan
SAShiva Raj Adhikari
Shiva Raj Adhikari
YZYuxin Zhao
Yuxin Zhao

1 March 2008 in Journal of Health Economics
Verified
Journal Article
Closed access
OOOwen O’donnell
Owen O’donnell
EDEddy van Doorslaer
Eddy van Doorslaer
RRRavi P. Rannan-Eliya
Ravi P. Rannan-Eliya
ASAparnaa Somanathan
Aparnaa Somanathan
SAShiva Raj Adhikari
Shiva Raj Adhikari
YZYuxin Zhao
Yuxin Zhao

1 January 2007 in The World Bank Economic Review
Verified
Journal Article
Closed access
PDF file
OOOwen O'Donnell
Owen O'Donnell
EDEddy van Doorslaer
Eddy van Doorslaer
RRRavi P. Rannan-Eliya
Ravi P. Rannan-Eliya
ASAparnaa Somanathan
Aparnaa Somanathan
SAShiva Raj Adhikari
Shiva Raj Adhikari
YZYuxin Zhao
Yuxin Zhao
The article compares the incidence of public healthcare across 11 Asian countries and provinces, testing the dominance of healthcare concentration curves against an equal distribution and Lorenz curves and across countries. The analysis reveals that the distribution of public healthcare is prorich in most developing countries. That distribution is avoidable, but a propoor incidence is easier to realize at higher national incomes. The experiences of Malaysia, Sri Lanka, and Thailand suggest that increasing the incidence of propoor healthcare requires limiting the use of user fees, or protecting the poor effectively from them, and building a wide network of health facilities. Economic growth may not only relax the government budget constraint on propoor policies but also increase propoor incidence indirectly by raising richer individuals' demand for private sector alternatives.

15 February 2023 in BMJ Open Diabetes Research & Care
Verified
Journal Article
Open access
PDF file
RRRavindra Prasan Rannan-Eliya
Ravindra Prasan Rannan-Eliya
NWNilmini Wijemunige
Nilmini Wijemunige
PPPrasadini Perera
Prasadini Perera
YKYasodhara Kapuge
Yasodhara Kapuge
NGNishani Gunawardana
Nishani Gunawardana
BPBilesha Perera
Bilesha Perera
Introduction This study’s objective was to produce robust, comparable estimates of the prevalence of diabetes and pre-diabetes in the Sri Lankan adult population, where previous studies suggest the highest prevalence in South Asia. Research design and methods We used data on 6661 adults from the nationally representative 2018/2019 first wave of the Sri Lanka Health and Ageing Study (SLHAS). We classified glycemic status based on previous diabetes diagnosis, and either fasting plasma glucose (FPG), or FPG and 2-hour plasma glucose (2-h PG). We estimated crude and age-standardized prevalence of pre-diabetes and diabetes and by major individual characteristics weighting the data to account for study design and subject participation. Results Crude prevalence of diabetes in adults was 23.0% (95% CI 21.2% to 24.7%) using both 2-h PG and FPG, and age-standardized prevalence was 21.8% (95% CI 20.1% to 23.5%). Using only FPG, prevalence was 18.5% (95% CI 7.1% to 19.8%). Previously diagnosed prevalence was 14.3% (95% CI 13.1% to 15.5%) of all adults. The prevalence of pre-diabetes was 30.5% (95% CI 28.2% to 32.7%). Diabetes prevalence increased with age until ages ≥70 years and was more prevalent in female, urban, more affluent, and Muslim adults. Diabetes and pre-diabetes prevalence increased with body mass index (BMI) but was as high as 21% and 29%, respectively, in those of normal weight. Conclusions Study limitations included using only a single visit to assess diabetes, relying on self-reported fasting times, and unavailability of glycated hemoglobin for most participants. Our results indicate that Sri Lanka has a very high diabetes prevalence, significantly higher than previous estimates of 8%–15% and higher than current global estimates for any other Asian country. Our results have implications for other populations of South Asian origin, and the high prevalence of diabetes and dysglycemia at normal body weight indicates the need for further research to understand the underlying drivers.